Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Long-Term Debt Issuances (2024)

Historic Long-Term Debt Issuances for Abeona Therapeutics (ABEO) over the last 1 years, with Q1 2024 value amounting to $20.0 million.

  • Abeona Therapeutics' Long-Term Debt Issuances changed N/A to $20.0 million in Q1 2024 from the same period last year, while for Dec 2024 it was $20.0 million, marking a year-over-year change of. This contributed to the annual value of $20.0 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Abeona Therapeutics reported Long-Term Debt Issuances of $20.0 million as of Q1 2024.
  • In the past 5 years, Abeona Therapeutics' Long-Term Debt Issuances ranged from a high of $20.0 million in Q1 2024 and a low of $20.0 million during Q1 2024